MS vs PLRX · P/E 20, $344.27B cap vs $77.3M cap
Morgan Stanley (MS) versus Pliant Therapeutics Inc (PLRX) — a side-by-side from cached financials, not a winner call.
Morgan Stanley (MS) is a capital markets company listed on US. It is led by Ted Pick.
Pliant Therapeutics Inc (PLRX) is a biotechnology company listed on US.
MS does not have a complete income-statement cache yet.
Latest reported PLRX revenue for 2024-12-31 was $0. Net income was -$210.3M. Revenue was down 100.0% from 2023-12-31 to 2024-12-31. PLRX currently screens at market cap $77.3M.
MS currently screens at market cap $344.27B and trailing P/E 19.8. PLRX currently screens at market cap $77.3M.
Not investment advice. Open the MS and PLRX stock pages for the full models.
Not investment advice.